Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism

Condition:   Primary Hyperparathyroidism Interventions:   Drug: Cinacalcet;   Drug: Placebo Sponsor:   Amgen Completed

Source: ClinicalTrials.gov - December 13, 2018 Category: Research Source Type: clinical trials